We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SCOTTSDALE, Ariz. — A novel therapeutic approach ...
The first FDA-approved treatment option for Sjögren's disease might be on the horizon, as neonatal Fc receptor (FcRn) blockers show promise in early data. B-cell activation in Sjögren's disease ...
Please provide your email address to receive an email when new articles are posted on . FcRn receptors have received FDA approvals in generalized myasthenia gravis. Studies of FcRn receptors in RA and ...
Viridian Therapeutics Inc. has disclosed a preclinical portfolio of neonatal Fc receptor (FcRn) inhibitors designed for next-generation treatment of antibody-mediated autoimmune diseases.
Autoimmune drug development increasingly recognizes that the Fc-FcR axis is more than an effector mechanism; it is a controllable immunological node that bridges humoral and cellular responses. This ...
SHIRLEY, NY, UNITED STATES, February 26, 2026 /EINPresswire.com/ — Creative BioMart, a global leader in biopharmaceutical research reagents and customized services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results